#Introducing another new board member! 💫 Julie Waras Brogren has joined PILA PHARMA in 2024 as Director of the Board and brings with her extensive experience in fundraising, finance, investor relation communication and developing strategies for advancing pharma assets from development to commercialization. Julie is currently Deputy CEO of Ascelia Pharma AB with responsibility for the duties of the Chief Financial Officer, including fundraising and managing Investor Relations, and Chief Commercial Officer, including Business Development. She comes with over 20 years of life science experience ranging from high-level positions at medical device companies to leadership positions in Danish big pharma Novo Nordisk in roles mainly bringing assets from clinical development to patients and markets globally 🌎 She also brings Board member and Board Chair experience in early-stage life science companies and crucially understands the maneuvers as a small listed company. Please join us in welcoming Julie – her contributions will be super valuable! More info in the link below! https://lnkd.in/dBScUjiz #PILA #Investment #Biotech #Lifesciences #Diabetes #Obesity
Michael Jensen
2mo
Tillykke, godt gået
Tillykke Julie💪🏻❤️🇩🇰
Great match! Congratulations both of you 👏💯
Tillykke Julie👌
Congratulation Julie and Pila Pharma
Congratulations! ✨
Tarek Mansour
2mo
Congratulations Julie Waras Brogren 👏
Linn Persson
2mo
Congratulations Julie and Pila Pharma!
MAIKEL HERNANDEZ
2mo
Congratulations 🥳 Julie Waras Brogren
Self Employed (Freelance)
2moCongratulations, Keep going